LIGAND PHARMACEUTICALS INC ($LGND)
Reardon Andrew โ CLO & Secretary
Shares
612
Price
$207.01
Total Value
$126,689.45
Nearby Earnings
Feb 26, 2026
EPS:Est: 1.46
Revenue:Est: $55.59M
Transaction Details
| Insider | Reardon Andrew |
|---|---|
| Title | CLO & Secretary |
| Transaction Date | Mar 4, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 6, 2026 |
| Shares Sold | 612 |
| Price per Share | $207.01 |
| Total Value | $126,689.45 |
| Shares Owned After | 39,457 |
| Derivative | No |
| Accession Number | 0002001011-26-000024 |
| Document | View SEC Filing |